title: Halofenate: effectiveness of two dosage forms and two dose schedules.
mesh_terms: D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001663:Bilirubin / Q000097:blood; D002214:Capsules; D002784:Cholesterol / Q000097:blood; D003402:Creatine Kinase / Q000097:blood; D004305:Dose-Response Relationship, Drug; D005260:Female; D006016:Glycolates / Q000008:administration & dosage*; D006218:Halofenate / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D006949:Hyperlipidemias / Q000145:classification; D000960:Hypolipidemic Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011517:Prothrombin Time; D012709:Serum Albumin / Q000032:analysis; D013607:Tablets; D013960:Thyroid Function Tests; D014280:Triglycerides / Q000097:blood*; D014527:Uric Acid / Q000097:blood*; D014528:Uricosuric Agents / Q000008:administration & dosage
chemical_list: D002214:Capsules; D006016:Glycolates; D000960:Hypolipidemic Agents; D012709:Serum Albumin; D013607:Tablets; D014280:Triglycerides; D014528:Uricosuric Agents; D014527:Uric Acid; D002784:Cholesterol; D003402:Creatine Kinase; D006218:Halofenate; D001663:Bilirubin